In view of the fact that the regulatory mechanisms of NF-κB signaling are extremely complex, the establishment of an animal model for DN and targeting renal CYLD intervention are necessary further studies, which will focus on the interaction among CYLD and inflammatory signaling to clarify the molecular mechanisms in the pathogenesis of DN and other diabetic complications. Here, NFKB1 is linked to liver dysplastic nodule.